.jpg)
.jpg)
01 Apr, 2020
GSK Acquires Tesaro in a USD 5.1 Billion Deal
GlaxoSmithKline (NYSE: GSK) announced on Monday that it will acquire Tesaro (NASDAQ: TSRO) for USD 5.1 Billion.This marks the first big acquisition since Hal Barron, a pharma veteran and experienced scientist took on the role of chief scientific off..
@Newsletter
Sign Up for Weekly UpdatesOpt-into our eNewsletter NOW! For the Latest Trending Financial News Topics in Cannabis, Tech, Biotechs, Precious Metals, Energy, Renewable Energy and much more!
No articles found.
.jpg){kind=small}
All rights reserved.
No portion of Financialinsiders.com may be duplicated, redistributed or manipulated in any form without our consent, violators will be prosecuted to the full extent of the law. By accessing any information beyond this page, you agree to abide by the Privacy Policy and Terms of Use (Disclaimer).